March 6, 2018 / 6:23 PM / 9 months ago

BRIEF-U.S. FDA Approves New HIV Treatment For Patients Who Have Limited Treatment Options

March 6 (Reuters) - U.S. Food and Drug Administration:

* U.S. FDA SAYS APPROVED ANTIRETROVIRAL MEDICATION TROGARZO (IBALIZUMAB-UIYK) FOR ADULT HIV PATIENTS WHO HAVE TRIED MULTIPLE HIV MEDICATIONS BEFORE

* U.S. FDA SAYS GRANTED APPROVAL OF TROGARZO TO TAIMED BIOLOGICS USA CORP Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below